These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 22459053

  • 21. Primary central nervous system lymphoma: overview of current treatment strategies.
    Brastianos PK, Batchelor TT.
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
    [Abstract] [Full Text] [Related]

  • 22. Patterns of treatment in older adults with primary central nervous system lymphoma.
    Panageas KS, Elkin EB, Ben-Porat L, Deangelis LM, Abrey LE.
    Cancer; 2007 Sep 15; 110(6):1338-44. PubMed ID: 17647247
    [Abstract] [Full Text] [Related]

  • 23. Primary central nervous system lymphoma after liver transplantation treated by radiosurgery combined with fractionated radiotherapy.
    Kim MS, Lee JI, Kim WS, Ko YH.
    J Clin Neurosci; 2009 Apr 15; 16(4):583-5. PubMed ID: 19200738
    [Abstract] [Full Text] [Related]

  • 24. [Recent advances in the treatment of primary central nervous system lymphoma].
    Nakamaki T.
    Brain Nerve; 2014 Aug 15; 66(8):969-79. PubMed ID: 25082318
    [Abstract] [Full Text] [Related]

  • 25. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
    Agarwal PA, Menon S, Smruti BK, Singhal BS.
    Neurol India; 2009 Aug 15; 57(6):756-63. PubMed ID: 20139505
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G, Müller F, Feuerhake F, Schäfer AO, Ostertag C, Finke J.
    Haematologica; 2008 Jan 15; 93(1):147-8. PubMed ID: 18166803
    [Abstract] [Full Text] [Related]

  • 28. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
    Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE.
    Cancer; 2008 Sep 01; 113(5):1025-31. PubMed ID: 18618509
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
    Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H, Van't Veer M, Hansen M, Soubeyran P, Taphoorn M, Thomas J, Van den Bent M, Fickers M, Van Imhoff G, Rozewicz C, Teodorovic I, van Glabbeke M, European Organization for Research and Treatment of Cancer Lymphoma Group.
    J Clin Oncol; 2003 Dec 15; 21(24):4483-8. PubMed ID: 14597741
    [Abstract] [Full Text] [Related]

  • 31. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
    Hoang-Xuan K, Taillandier L, Chinot O, Soubeyran P, Bogdhan U, Hildebrand J, Frenay M, De Beule N, Delattre JY, Baron B, European Organization for Research and Treatment of Cancer Brain Tumor Group.
    J Clin Oncol; 2003 Jul 15; 21(14):2726-31. PubMed ID: 12860951
    [Abstract] [Full Text] [Related]

  • 32. Management of primary central nervous system lymphoma.
    Royer-Perron L, Hoang-Xuan K.
    Presse Med; 2018 Jul 15; 47(11-12 Pt 2):e213-e244. PubMed ID: 30416008
    [Abstract] [Full Text] [Related]

  • 33. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Yamanaka R, Morii K, Shinbo Y, Takeuchi S, Tamura T, Hondoh H, Takahashi H, Onda K, Takahashi H, Tanaka R.
    Ann Hematol; 2005 Jul 15; 84(7):447-55. PubMed ID: 15747120
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
    Ney DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LE.
    Cancer; 2010 Oct 01; 116(19):4605-12. PubMed ID: 20572045
    [Abstract] [Full Text] [Related]

  • 37. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.
    Roth P, Martus P, Kiewe P, Möhle R, Klasen H, Rauch M, Röth A, Kaun S, Thiel E, Korfel A, Weller M.
    Neurology; 2012 Aug 28; 79(9):890-6. PubMed ID: 22895585
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. New treatment approaches in primary central nervous system lymphoma.
    Soussain C, Hoang-Xuan K, Doolittle ND.
    Hematol Oncol Clin North Am; 2005 Aug 28; 19(4):719-28, vii. PubMed ID: 16083832
    [Abstract] [Full Text] [Related]

  • 40. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.
    Ai Zheng; 2006 Apr 28; 25(4):476-80. PubMed ID: 16613684
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.